If approved, it could have the potential to reshape how severe hypoglycemia is treated. -Craig Idlebrook/GluCraig UPDATE – 7/25/2018 – Lilly clarifies that they are asking for the FDA and the EMA to approve this drug for both people with both type 1 diabetes and people with type 2 diabetes to use. Nasal glucagon is going […]
Xeris Asks FDA to Approve Ready-to-Use Glucagon Pen
It would be the first room temperature-stable liquid glucagon on the market.